Serum and glucocorticoid kinase 3 at 8q13.1 promotes cell proliferation and survival in hepatocellular carcinoma.
about
The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent updateCharacterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinaseSGK3 is an androgen-inducible kinase promoting prostate cancer cell proliferation through activation of p70 S6 kinase and up-regulation of cyclin D1.Identification of Host Kinase Genes Required for Influenza Virus Replication and the Regulatory Role of MicroRNAs.Loss of serum and glucocorticoid-regulated kinase 3 (SGK3) does not affect proliferation and survival of multiple myeloma cell linesSGK3 (CISK) may induce tumor angiogenesis (Hypothesis).Serum- and glucocorticoid-regulated protein kinase 3 overexpression promotes tumor development and aggression in breast cancer cells.Coordinated regulation of serum- and glucocorticoid-inducible kinase 3 by a C-terminal hydrophobic motif and Hsp90-Cdc37 chaperone complexMiR-155 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells through the activation of PI3K/SGK3/β-catenin signaling pathwaysAKT-independent PI3-K signaling in cancer - emerging role for SGK3.SGK2 promotes hepatocellular carcinoma progression and mediates GSK-3β/β-catenin signaling in HCC cells.MiR-212-3p inhibits glioblastoma cell proliferation by targeting SGK3.The long non-coding RNA, SNHG6-003, functions as a competing endogenous RNA to promote the progression of hepatocellular carcinoma.Prolonged inhibition of class I PI3K promotes liver cancer stem cell expansion by augmenting SGK3/GSK-3β/β-catenin signalling.LncRNA SNHG5 promotes the progression of osteosarcoma by sponging the miR-212-3p/SGK3 axis
P2860
Q27003050-E2BFDC69-2340-4537-8E72-CF9E4CA0745BQ30427499-AEFB4C49-C528-4E14-A7B9-6646ED007E36Q33701389-D7825FA9-3A34-4B3D-8890-3BF59BF82CDFQ34785589-57A8BF65-1625-4FC6-AC02-C9DD85444EF7Q35594600-28132590-195A-488E-B125-2AD379905A66Q35803551-6A5C3C1F-7A97-4F5B-9D33-0811D43B3A00Q36080490-48C0F030-5513-4D61-8521-B1BA4AC75863Q37596323-ECE81B48-AAF1-48AA-A892-1A6800033636Q37662358-D278ECD9-D564-4DE4-B526-014D60464CADQ38134714-A8D32724-8CF0-4AEA-B46B-C457B1EDF9CDQ38699399-D5CB59C8-5174-4E6B-84AF-75C9148D0392Q38905757-796E5CF0-F49E-451A-90C8-3535AFC4A69BQ40573712-783600DB-DFE9-4003-B899-E93C097D5386Q55510801-F10B0FAC-7C33-4467-A9FE-0EB8282B7721Q57155419-1F8D045F-2619-4A0C-9C64-1D724A6CDBA7
P2860
Serum and glucocorticoid kinase 3 at 8q13.1 promotes cell proliferation and survival in hepatocellular carcinoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Serum and glucocorticoid kinas ...... l in hepatocellular carcinoma.
@en
Serum and glucocorticoid kinas ...... l in hepatocellular carcinoma.
@nl
type
label
Serum and glucocorticoid kinas ...... l in hepatocellular carcinoma.
@en
Serum and glucocorticoid kinas ...... l in hepatocellular carcinoma.
@nl
prefLabel
Serum and glucocorticoid kinas ...... l in hepatocellular carcinoma.
@en
Serum and glucocorticoid kinas ...... l in hepatocellular carcinoma.
@nl
P2093
P50
P356
P1433
P1476
Serum and glucocorticoid kinas ...... al in hepatocellular carcinoma
@en
P2093
Tim Hon Man Chan
Ting-Ting Zeng
P304
P356
10.1002/HEP.25584
P407
P577
2012-04-23T00:00:00Z